1.
Bioorg Med Chem Lett
; 20(2): 673-8, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20006497
RESUMO
2,3,5-Trisubstituted pyridines have been designed as potent AKT inhibitors that are selective against ROCK1 based on the comparison between AKT and ROCK1 structures. Substitution at the 2-position of the core pyridine is the key element to provide selectivity against ROCK1. An X-ray co-crystal structure of 9p in PKA supports the proposed rationale of ROCK1 selectivity.